We would love to hear your thoughts about our site and services, please take our survey here.
But he does talk of the 4 (+) tests AVCT have helped to develop
1 lateral flow. For professionals and direct to homes.(millions per day)
2. BAMS mass spectrometry test for the 200 + MS machines in UK, capable of a 1000 each per day.
3. ELISA. Professional test
4. Waste water SKIN test
Plus the manufacturing partnership with RTC companies for mass screening and tracing.
So whilst he is not talking about moonshot, he basically is!!!
More testing needed!
Think 3800 would be world wide. NHS has 103 path labs
Sorry, Just being pedantic on updating versions of documents.
It is a massive step forward + talk of Sona also. Great news at the end of a difficult day.
Not a great start.
The Adeptrix product data sheet dated 15/9/2020, includes an updated reference to a document dated 29/9/2020?
From Monday’s interims
“ There are multiple other opportunities in the pipeline that have been created by the SARS-CoV-2 spike protein binding Affimers, such as the BAMSTM assay with Adeptrix and several others that we will update the market on in due course. We are working tirelessly to bring all of these opportunities to the point of revenue generation as quickly as we possibly can.”
So Sona could be one of the several others.
Yes great find Hurst. Much more detail than yesterday's update, looks great. Can anyone see a date of publication?
Zz. So true, I was getting carried away!
Does anyone else feel like the cork is just about to explode, after 6 months of giving the bottle a good shaking?
Next week is going to be revealing.
GLA
Gordon Brown IS certainly aware of the Avacta LFD antigen test, when he said this morning about a mass produced new pregnancy style test, almost ready.
If this is added to the “4th LFT saliva validation” discussion, along with “holly grail” comments, then we will have major news incoming very very soon in this regard
Definitely looking forward to next week.
GLA
This is a strange tweet, is GJB just playing with us?
gkb47. Good post.
So the antigen lateral flow test clinical evaluation center is up and running, in the Manchester area.
This is for us.
We are so close!!
Lennard YW Lee, (UHB/ University of Birmingham)
@drlennardlee
·
1h
We have completed site initiation visit for the UK lateral flow antigen testing study as part of #moonshot evaluation. Well run centres.
@MFTnhs
research nurse Anila is confident it’s unusual but
@falcon_study
is going to be a success!
Great news
This is new as I checked the adeptrix site on Friday. It seems to fit but are we sure it's the AVCT test?
Just looked at these, Carclo -CAR, they are a minnow. in comparison to AVCT (Mcap only 12m)!
However, they are similar to us in regard to the unfortunate Covid 19 offering opportunities of game changing proportions. Their primary business seems to be the manufacture of Medical diagnostics plastic products of high specification.
Over the last few years it looks like their share price again has a had similar profile to ours from the highs of 400+p to the lows of 8p now starting to rise abit. Hopefully they will be involved in supplying the to the 10’s of millions of outer casings to our LFD, over the next few months and years as they seem like a quality uk outfit, and it just adds to our British success story.
It seems that the stars are all starting to align for us after 5months of hard toil from our team. The initial target outlined by Alistair in his first webcast on the idea, all those months ago of producing a lateral flow strip to test for the Covid antigens from saliva samples, is now exactly what the Country/Gov/World are only now crying out for.
The next RNS will be massive.
GLA
Press release I posted last week
Daewoong ph1 trial01 Sep 2020 07:40
Hopefully this trial is in combination with Avacta’s jv. We then get an early indication of Affimers in humans, things moving fast.
https://www3.bkpm.go.id/en/publication/detail/news/ministry-of-health-conducts-mesenchymal-stem-cell-therapy-clinical-trials-f
This could lead to affimers being trialed in humans very quickly and at no cost to Avacta!!
BBI basically run a production line, they will have secured many orders for this line prior to us turning up.
Albeit they mentioned an accelerated process, AVCT will still be in a que to have their test batch run. They will only get close to their turn on the production line once all the tech transfer, tooling, materials, procedures are all available at site.
BBI have just done the batch run for the other cv19 antibody test they are involved with, they may be also involved with other customers lfd orders (non covid).
They will hopefully have now cleared the decks and building the line for Avacta's batch.
Whilst it would be nice to have had earlier news updates on the batch production, this time period imho is not unrealistic.
Batch production runs are always slower due to the set up time, smaller quantities, teething problems etc.
Just found this from Web industries , they have hired an extra 175 to ramp up production in the last 6 weeks!
http://www.medicaldesignandoutsourcing.com/3-things-to-scale-up-when-outsourcing-covid-19-test-production/
Moderna,
+ Earlier in the year they were the only one around a Whitehouse table of world leading pharma excs to suggest a vaccine possible this year.
+ receives massive $ 500m support for vaccine development from trump.
+ executive Moncef Slaoui, becomes a leader of operation warp speed.
+ get order for 100m doses of potential new vaccine, from trump.
+ who do not release full and complete ph1 data.
+ who despite other proven vaccine manufacturers, saying longer timescales somehow offer a magical quick route solution.
+ who have NEVER before taken a vaccine to market.
A total Trump political stunt no more no less, playing with huge numbers of people's lives, fast and loose.
Just from memory, Wasn't part of the 48m cash raise going towards increased production facilities for affimer generation?